Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
11/23/2011 | EP2387573A1 6-phenyl-lh-imidazo ý4, 5-c¨pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors |
11/23/2011 | EP2387315A1 IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS |
11/23/2011 | EP2260033B1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
11/23/2011 | EP1943221B1 Piperazine amidines as antiviral agents |
11/23/2011 | EP1391451B1 2-iminopyrrolidine derivates |
11/23/2011 | CN102256975A Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative |
11/23/2011 | CN102256974A Substituted bicyclic imidazole derivatives as gamma secretase modulators |
11/23/2011 | CN102256963A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
11/23/2011 | CN102250203A Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
11/23/2011 | CN102250092A Preparation process of alkaloid tabersonine |
11/23/2011 | CN102250091A Fluorine-containing fluorescent compounds and preparation method thereof |
11/23/2011 | CN102250090A Method for preparing minodronic acid intermediate |
11/23/2011 | CN102250089A Beta-carboline alkaloid and application thereof to preparing antimalarial medicaments |
11/23/2011 | CN102250088A Salt of N-methylated 8-methoxy ouinolone carboxylic acid compound, preparation method and use thereof |
11/23/2011 | CN102250071A Pyrazole compounds useful as protein kinase inhibitors |
11/23/2011 | CN101356174B Indol-3-yl-carbonyl-spiro-piperidine derivatives |
11/23/2011 | CN101326184B 二杂环咪唑基化合物 Two heterocyclic imidazole compound |
11/22/2011 | US8063219 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments |
11/22/2011 | US8063214 Polymorphic forms of tadalafil |
11/22/2011 | US8063064 Non-nucleoside reverse transcriptase inhibitors |
11/22/2011 | US8063063 Immunopotentiating compounds |
11/22/2011 | US8063061 6-(2-amino-1,3-thiazol-4-yl)-3-(2,4-dichlorophenyl)-1-methyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; affinity for GABAA-receptor-associated omega modulatory sites |
11/22/2011 | US8063044 Pyrazole derivatives |
11/22/2011 | CA2558509C Tetrahydropyridoindole derivatives |
11/22/2011 | CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
11/22/2011 | CA2471262C Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors |
11/17/2011 | WO2011143657A1 Male contraceptive compositions and methods of use |
11/17/2011 | WO2011143646A1 Fused bicyclic kinase inhibitors |
11/17/2011 | WO2011143645A1 Fused bicyclic kinase inhibitors |
11/17/2011 | WO2011143495A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
11/17/2011 | WO2011143459A1 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
11/17/2011 | WO2011143444A2 Diphenylbutypiperidine autophagy inducers |
11/17/2011 | WO2011143366A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
11/17/2011 | WO2011143365A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
11/17/2011 | WO2011143150A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
11/17/2011 | WO2011143148A1 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
11/17/2011 | WO2011143129A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors |
11/17/2011 | WO2011143106A1 Bi - functional pyrazolopyridine compounds |
11/17/2011 | WO2011142381A1 Benzo- or pyrido-imidazole derivative |
11/17/2011 | WO2011142316A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
11/17/2011 | WO2011141729A1 Novel compounds |
11/17/2011 | WO2011141728A1 Spirocyclic derivatives with affinity for calcium channels |
11/17/2011 | WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
11/17/2011 | WO2011113798A3 Inhibitors of semicarabazide - sensitive amine oxidase |
11/17/2011 | WO2011084434A3 Aza-ring fused indole and indoline derivatives |
11/17/2011 | WO2011082270A3 Substituted imidazopyridinyl-aminopyridine compounds |
11/17/2011 | WO2011079133A3 Compounds and methods for kinase modulation, and indications therefor |
11/17/2011 | US20110282063 Method of producing a diazafluorene compound |
11/17/2011 | US20110282060 Nitric oxide-releasing diazeniumdiolated compounds |
11/17/2011 | US20110282056 Protein kinase inhibitors and use thereof |
11/17/2011 | US20110282055 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
11/17/2011 | US20110281888 Fused Bicyclic Kinase Inhibitors |
11/17/2011 | US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
11/17/2011 | US20110281878 INHIBITORS OF p38 |
11/17/2011 | US20110281875 Inhibitors of IAP |
11/17/2011 | US20110281874 2-aminopyridine analogs as glucokinase activators |
11/17/2011 | US20110281865 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases |
11/17/2011 | US20110281864 Pyrido[3,2-d]Pyridazine-2(1H)-One Compounds as p38 Modulators and Methods of Use Thereof |
11/17/2011 | US20110281862 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl |
11/17/2011 | US20110281845 Organic compounds |
11/17/2011 | US20110281842 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
11/17/2011 | US20110281838 5-alkynyl-pyrimidines |
11/17/2011 | US20110281837 3-substituted-6-aryl pyridines |
11/17/2011 | US20110281290 Sox-based kinase sensor |
11/17/2011 | US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins |
11/17/2011 | US20110279025 Novel chrysene compound and organic light-emitting device having the compound |
11/17/2011 | CA2835596A1 Benzo- or pyrido-imidazole derivative |
11/17/2011 | CA2800578A1 Nitrogen-heterocyclic compounds as phosphodiesterase 10 inhibitors |
11/17/2011 | CA2799162A1 Treatment of mci and alzheimer's disease |
11/17/2011 | CA2799156A1 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
11/17/2011 | CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
11/17/2011 | CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
11/17/2011 | CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
11/17/2011 | CA2790847A1 Fused bicyclic kinase inhibitors |
11/16/2011 | EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response |
11/16/2011 | EP2386558A1 CGRP antagonists |
11/16/2011 | EP2386557A1 Novel substituted imidazoquinolines |
11/16/2011 | EP2385944A2 Fluorine containing compounds and methods of use thereof |
11/16/2011 | EP2385942A1 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases |
11/16/2011 | EP2225243B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
11/16/2011 | EP1885722B1 Quinoline derivatives as ep4 antagonists |
11/16/2011 | EP1784404B1 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
11/16/2011 | EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
11/16/2011 | CN1930160B Hiv integrase inhibitors |
11/16/2011 | CN102245605A Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
11/16/2011 | CN102245604A Anti-viral compounds |
11/16/2011 | CN102245028A Spiroheterocyclic N-oxypiperidines as pesticides |
11/16/2011 | CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
11/16/2011 | CN102241678A Antitumor effect and application of alicyclic structure-containing compound |
11/16/2011 | CN102241677A Purification method of spherosin |
11/16/2011 | CN102241676A Tetrahydropyridone 1,3-diazacyclo cis-neonicotine compounds as well as preparation method and applications thereof |
11/16/2011 | CN102241675A (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof |
11/16/2011 | CN102241674A Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester |
11/16/2011 | CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof |
11/16/2011 | CN101475597B Preparation and use of ruthenium and iridium metal complex singlet oxygen fluorescent probe |
11/16/2011 | CN101305004B Novel diazabicyclic aryl derivatives and their medical use |
11/16/2011 | CN101304999B Non-steroidal compounds useful as glucocorticoid receptor modulators |
11/15/2011 | US8058452 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
11/15/2011 | US8058445 Substituted pyridinecarboxamides for the treatment of cancer |
11/15/2011 | US8058436 Method for the preparation of enantiomerically pure mirtazapine |